Publications

Carr JP. et al, (2022), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Addressing vaccine inequities among Ukrainian refugees.

Hill M. et al, (2022), Lancet Infect Dis, 22, 935 - 936

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females

Marchevsky NG. et al, (2022), eBioMedicine, 81, 104128 - 104128

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.

Tuekprakhon A. et al, (2022), Cell, 185, 2422 - 2433.e13

Effect of childhood vaccination and antibiotic use on pneumococcal populations and genome-wide associations with disease among children in Nepal: an observational study.

Kandasamy R. et al, (2022), The Lancet. Microbe, 3, e503 - e511

Systematic review of host genomic biomarkers of invasive bacterial disease: Distinguishing bacterial from non-bacterial causes of acute febrile illness.

Kelly E. et al, (2022), EBioMedicine, 81

Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials

Billard MN. et al, (2022), Journal of Clinical Epidemiology, 147, 11 - 20

Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus.

Sheerin D. et al, (2022), Cell & bioscience, 12

Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.

Rollier CS. et al, (2022), Vaccine

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.

Nutalai R. et al, (2022), Cell, 185, 2116 - 2131.e18

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.

Li G. et al, (2022), Lancet (London, England), 399, 2212 - 2225

Viral vector vaccines.

McCann N. et al, (2022), Current opinion in immunology, 77

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.

Li Y. et al, (2022), Lancet (London, England), 399, 2047 - 2064

Future reporting of vaccine uptake needs to include any change in ethnic or socioeconomic disparities.

Hoang U. et al, (2022), BMJ (Clinical research ed.), 377

Adenovirus vectors activate Vδ2 + γδT cells in a type I interferon‐, TNF‐, and IL‐18‐dependent manner

Provine NM. et al, (2022), European Journal of Immunology, 52, 835 - 837

Innovative vaccine approaches-a Keystone Symposia report.

Cable J. et al, (2022), Annals of the New York Academy of Sciences, 1511, 59 - 86

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

Ogbe A. et al, (2022), JCI Insight, 7

National rates and disparities in childhood vaccination and vaccine-preventable disease during the COVID-19 pandemic: English sentinel network retrospective database study.

Hoang U. et al, (2022), Arch Dis Child

Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCR.

Ratcliff J. et al, (2022), Journal of clinical microbiology

CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination

Sharpe HR. et al, (2022), JCI Insight, 7

Genetic Susceptibility to Enteric Fever in Experimentally Challenged Human Volunteers.

Barton A. et al, (2022), Infection and immunity

Public engagement during a typhoid conjugate vaccine trial in Lalitpur, Nepal- experience, challenges and lessons learnt.

Dahal A. et al, (2022), Human vaccines & immunotherapeutics, 1 - 5

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Ahern DJ. et al, (2022), Cell, 185, 916 - 938.e58

Decoupling of omicron variant infections and severe COVID-19.

Madhi SA. et al, (2022), Lancet (London, England), 399, 1047 - 1048

Viral Vectors Expressing Group B Meningococcal Outer Membrane Proteins Induce Strong Antibody Responses but Fail to Induce Functional Bactericidal Activity in Mice.

Marsay L. et al, (2022), The Journal of infection

“It seems impossible that it’s been made so quickly”: a qualitative investigation of concerns about the speed of COVID-19 vaccine development and how these may be overcome

Brown P. et al, (2022), Human Vaccines & Immunotherapeutics, 1 - 8

Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study.

Birger R. et al, (2022), The Lancet. Infectious diseases

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.

Costa Clemens SA. et al, (2022), Lancet (London, England)

Indirect effects of the covid-19 pandemic on childhood infection in England: population based observational study

Kadambari S. et al, (2022), BMJ, e067519 - e067519

COVID-19 vaccine strategies must focus on severe disease and global equity.

McIntyre PB. et al, (2022), Lancet (London, England), 399, 406 - 410

Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity.

Sluder AE. et al, (2022), Frontiers in immunology, 13

International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease

Gladstone RA. et al, (2022), Vaccine

Safety of the Fiocruz ChAdOx COVID-19 vaccine used in a mass vaccination campaign in Botucatu, Brazil

Clemens SAC. et al, (2022), Vaccine

Childhood Invasive Bacterial Disease in Kathmandu, Nepal (2005-2013).

Carter MJ. et al, (2021), The Pediatric infectious disease journal

The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis.

Oguti B. et al, (2021), Vaccine

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.

Dejnirattisai W. et al, (2021), Lancet (London, England)

Cookies on this website

Publications